TherapeuticsMD, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
TherapeuticsMD, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2011 to Q2 2024.
  • TherapeuticsMD, Inc. Depreciation, Depletion and Amortization for the quarter ending June 30, 2024 was $180K, a 40.6% increase year-over-year.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $180K +$52K +40.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q2 2023 $128K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2012 $14.6K +$867 +6.32% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-11
Q1 2011 $13.7K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.